Index / Neocutis / Growth Factor Serum
Neocutis

Growth Factor Serum.

Neocutis Growth Factor Serum
Serums

Guru Score

66%

Mixed

Early verdict · Few reviews so far
2Gurus
0Yay
2Mixed
0Nay

What the gurus are saying

HotandFlashy and Dr Dray are mixed. HotandFlashy: "All subjects thought the eyelids treated with their product had a better Scar and overall appearance than the fellow eyelids"
Synthesized from 2 expert reviews · most recent take September 2024

What the gurus are saying.

Every take we've logged from this product's reviews across YouTube. Click any row to watch the moment they said it.

All takes Yay takes Nay takes Mixed takes Hide sponsored
~Mixed
"All subjects thought the eyelids treated with their product had a better Scar and overall appearance than the fellow eyelids"
~Mixed
"Neocutis makes a Growth Factor Serum I reviewed a long time ago that's pretty good, but when I used it I was just kind of underwhelmed by it personally."

Frequently asked.

Is Neocutis Growth Factor Serum worth it?

The gurus mostly approve it, but with enough reservations to keep it in the middle at a Guru Score of 66%.

What is Neocutis Growth Factor Serum's Guru Score?

Neocutis Growth Factor Serum holds a Guru Score of 66%. That is our read on how warmly the experts talk about it, based on the verdicts of 2 expert reviewers we have collected.

Cheaper alternatives the gurus rate.

Lower-priced serums the gurus still rate highly, versus this luxury pick.

See how they stack up →

Similar products worth a look.

Other products the same gurus have weighed in on, plus more from this brand and category.

Compare side by side →

Share this score

Add this badge to your blog or website. It links back to this page and updates itself when the experts change their minds. Free, no sign-up.

Then paste it into your site's HTML or embed block.

This week's top beauty news, in your inbox.

A weekly read of the takes worth catching up on: the raves, the splits, the ones the gurus won't shut up about. Free, no spam, unsubscribe whenever.

Subscribe to the digest